Literature DB >> 19925609

Clinical performance of the St. Jude Medical Riata defibrillation lead in a large patient population.

James G Porterfield1, Linda M Porterfield, Karl H Kuck, Raffaele Corbisiero, Steven M Greenberg, Gerhard Hindricks, Oussama Wazni, Scott L Beau, John M Herre.   

Abstract

OBJECTIVE: The purpose of this large multicenter study was to evaluate the long-term reliability of an implantable cardioverter defibrillator (ICD) lead to determine the incidence of adverse events (AEs).
BACKGROUND: A recent concern has been the performance of cardiac defibrillator leads. There have been conflicting reports regarding the rate of lead perforation and other AEs.
METHODS: Medical records from patients implanted from 6-1-2001 to 11-27-2007 with the St. Jude Medical Riata family of RV leads at 23 US (N = 12,969) and 5 German (N = 2,418) centers were reviewed for chronic lead-related AEs. These included perforation, dislodgment, conductor fracture and insulation damage. The mean follow-up period was 18.0 months. AEs were defined as those that required Riata lead revision, extraction, or replacement.
RESULTS: The incidence of lead AEs was <1% for each AE type. Perforation occurred in 0.38%, dislodgement in 0.93%, conductor fracture in 0.18%, and insulation damage in 0.21% of patients studied.
CONCLUSIONS: During the follow-up of the 15,387 patients with Riata leads, the incidence of AEs which included perforation, dislodgement, conductor fraction and insulation damage was low and within the range of what is considered clinically acceptable.

Entities:  

Mesh:

Year:  2009        PMID: 19925609     DOI: 10.1111/j.1540-8167.2009.01651.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  4 in total

1.  Prospective evaluation of cinefluoroscopy and chest radiography for Riata lead defects: implications for future lead screening.

Authors:  Peem Lorvidhaya; Ivan Mendoza; Sharmila Sehli; Michael K Atalay; Michael H Kim
Journal:  J Interv Card Electrophysiol       Date:  2013-09-08       Impact factor: 1.900

2.  Long-term performance of the St Jude Riata 1580-1582 ICD lead family.

Authors:  S D A Valk; D A M J Theuns; L Jordaens
Journal:  Neth Heart J       Date:  2013-03       Impact factor: 2.380

Review 3.  Adverse events following implantable cardioverter defibrillator implantation: a systematic review.

Authors:  Rebecca Persson; Amy Earley; Ann C Garlitski; Ethan M Balk; Katrin Uhlig
Journal:  J Interv Card Electrophysiol       Date:  2014-06-20       Impact factor: 1.900

4.  Transvenous implantable cardioverter-defibrillator lead reliability: implications for postmarket surveillance.

Authors:  Daniel B Kramer; Laura A Hatfield; Deepa McGriff; Christopher R Ellis; Melanie T Gura; Michelle Samuel; Linda Kallinen Retel; Robert G Hauser
Journal:  J Am Heart Assoc       Date:  2015-05-29       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.